Cross Country Healthcare buy Barrington Research
Start price
29.11.23
/
50%
€18.50
Target price
29.11.24
€23.68
Performance (%)
-41.62%
End price
30.11.24
€10.80
Summary
This prediction ended on 30.11.24 with a price of €10.80. The BUY prediction by Barrington_Research for Cross Country Healthcare performed very badly with a performance of -41.62%. Barrington_Research has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Cross Country Healthcare | 0.000% | 0.000% | -7.965% |
| iShares Core DAX® | -0.917% | -3.612% | 22.956% |
| iShares Nasdaq 100 | -3.301% | -0.193% | 10.320% |
| iShares Nikkei 225® | -4.194% | 3.000% | 18.193% |
| iShares S&P 500 | -1.866% | -0.116% | 5.023% |
Comments by Barrington_Research for this prediction
In the thread Cross Country Healthcare diskutieren
Cross Country Healthcare, Inc. (NASDAQ: CCRN) had its price target lowered by analysts at Barrington Research from $29.00 to $26.00. They now have an "outperform" rating on the stock.
Ratings data for CCRN provided by MarketBeat
In the thread Trading Cross Country Healthcare
Die von Barrington_Research gewählte maximale Laufzeit wurde überschritten
Stopped prediction by Barrington_Research for Cross Country Healthcare
Cross Country Healthcare
Start price
Target price
Perf. (%)
€13.90
08.08.24
08.08.24
€17.41
08.08.25
08.08.25
-22.30%
09.08.25
09.08.25
Cross Country Healthcare
Start price
Target price
Perf. (%)
€15.40
06.05.24
06.05.24
€19.47
06.05.25
06.05.25
-20.78%
07.05.25
07.05.25
Cross Country Healthcare
Start price
Target price
Perf. (%)
€16.90
27.02.24
27.02.24
€22.11
27.02.25
27.02.25
-2.96%
28.02.25
28.02.25